• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PTRF/Cavin1 作为神经胶质瘤和血清外泌体生物标志物的作用。

The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.

机构信息

Tianjin Neurological Institute, Key Laboratory of Post-neurotrauma Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin 300052, China.

Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin 300052, China.

出版信息

Theranostics. 2018 Feb 7;8(6):1540-1557. doi: 10.7150/thno.22952. eCollection 2018.

DOI:10.7150/thno.22952
PMID:29556340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5858166/
Abstract

Exosomes play critical roles in intercellular communication in both nearby and distant cells in individuals and organs. Polymerase I and transcript release factor (PTRF), also known as Cavin1, has previously been described as a critical factor in caveola formation, and aberrant PTRF expression has been reported in various malignancies. However, the function of PTRF in tumor progression remains controversial, and its role in glioma is poorly understood. In this study, we report that PTRF is associated with malignancy grade and poor prognosis in glioma patients. Our previous study using two proteomics methods, tandem mass tag (TMT) and data-independent acquisition (DIA), showed that EGFRvIII overexpression increased PTRF expression at the protein level. In contrast, blocking PI3K and AKT using LY294002 and MK-2206, respectively, decreased PTRF expression, showing that PTRF is regulated in the EGFR/PI3K/AKT pathway. ChIP-PCR analysis showed that PTRF is transcriptionally regulated by the H3K4me3 and H3K27me3 modifications. Furthermore, PTRF overexpression increased exosome secretion and induced cell growth in vitro. More importantly, overexpressing PTRF induced the malignancy of nearby cells in vivo, suggesting that PTRF alters the microenvironment through intercellular communication via exosomes. Furthermore, analysis of clinical samples showed a positive correlation between tumor grade and PTRF expression in both tumor tissues and exosomes isolated from blood harvested from glioma patients, and PTRF expression in exosomes isolated from the sera of GBM patients was decreased after surgery. In conclusion, PTRF serves as a promising biomarker in both tumor samples and serum exosomes, thus facilitating the detection of glioma and potentially serving as a therapeutic target for glioblastoma multiforme.

摘要

外泌体在个体和器官中邻近和远处细胞的细胞间通讯中发挥着关键作用。聚合酶 I 和转录释放因子(PTRF),也称为 Cavin1,先前被描述为形成小窝的关键因素,并且在各种恶性肿瘤中已经报道了异常的 PTRF 表达。然而,PTRF 在肿瘤进展中的功能仍然存在争议,其在神经胶质瘤中的作用知之甚少。在这项研究中,我们报告 PTRF 与神经胶质瘤患者的恶性程度和预后不良相关。我们之前使用两种蛋白质组学方法,串联质量标签(TMT)和数据非依赖性采集(DIA)的研究表明,EGFRvIII 过表达增加了 PTRF 在蛋白质水平上的表达。相比之下,分别使用 LY294002 和 MK-2206 阻断 PI3K 和 AKT,降低了 PTRF 的表达,表明 PTRF 在 EGFR/PI3K/AKT 通路中受到调控。ChIP-PCR 分析表明,PTRF 是由 H3K4me3 和 H3K27me3 修饰转录调控的。此外,PTRF 过表达增加了外泌体的分泌并诱导体外细胞生长。更重要的是,过表达 PTRF 诱导体内邻近细胞的恶性转化,表明 PTRF 通过外泌体通过细胞间通讯改变微环境。此外,对临床样本的分析表明,肿瘤组织和从神经胶质瘤患者采集的血液中分离的外泌体中肿瘤分级与 PTRF 表达之间存在正相关,并且从 GBM 患者血清中分离的外泌体中的 PTRF 表达在手术后降低。总之,PTRF 既是肿瘤样本又是血清外泌体中的有前途的生物标志物,因此有利于检测神经胶质瘤,并可能成为多形性胶质母细胞瘤的治疗靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/fe7344704980/thnov08p1540g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/d08b6cba1e62/thnov08p1540g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/518757e4ebbb/thnov08p1540g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/6aa22fcc47f3/thnov08p1540g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/1aa0dfac65b0/thnov08p1540g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/070e97b5e4c0/thnov08p1540g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/ad925ff48b18/thnov08p1540g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/7c5e64eb23a1/thnov08p1540g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/a62b28796bac/thnov08p1540g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/fe7344704980/thnov08p1540g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/d08b6cba1e62/thnov08p1540g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/518757e4ebbb/thnov08p1540g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/6aa22fcc47f3/thnov08p1540g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/1aa0dfac65b0/thnov08p1540g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/070e97b5e4c0/thnov08p1540g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/ad925ff48b18/thnov08p1540g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/7c5e64eb23a1/thnov08p1540g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/a62b28796bac/thnov08p1540g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0722/5858166/fe7344704980/thnov08p1540g009.jpg

相似文献

1
The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.PTRF/Cavin1 作为神经胶质瘤和血清外泌体生物标志物的作用。
Theranostics. 2018 Feb 7;8(6):1540-1557. doi: 10.7150/thno.22952. eCollection 2018.
2
PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.PTRF/CAVIN1 通过 EGFR 通路受 SHC1 调控,可作为 ccRCC 的潜在生物标志物存在于尿液外泌体中。
Carcinogenesis. 2020 May 14;41(3):274-283. doi: 10.1093/carcin/bgz147.
3
UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.UBE2O 泛素化 PTRF/CAVIN1 并抑制外泌体相关 PTRF/CAVIN1 的分泌。
Cell Commun Signal. 2022 Nov 28;20(1):191. doi: 10.1186/s12964-022-00996-z.
4
Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.上皮膜蛋白 1 通过 PI3K/AKT/mTOR 信号通路促进胶质母细胞瘤进展。
Oncol Rep. 2019 Aug;42(2):605-614. doi: 10.3892/or.2019.7204. Epub 2019 Jun 19.
5
Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.脑胶质瘤侵袭潜能与形成小窝的蛋白 caveolin-1 和 CAVIN1 表达的相关性。
J Neurooncol. 2019 Jun;143(2):207-220. doi: 10.1007/s11060-019-03161-8. Epub 2019 Apr 4.
6
TRAM2 promotes the malignant progression of glioma through PI3K/AKT/mTOR pathway.TRAM2 通过 PI3K/AKT/mTOR 通路促进胶质瘤的恶性进展。
Biochem Biophys Res Commun. 2022 Jan 1;586:34-41. doi: 10.1016/j.bbrc.2021.11.061. Epub 2021 Nov 19.
7
PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways.PRL-3 是胶质母细胞瘤的一个潜在预后标志物,通过 ERK 和 JNK 通路增强 MMP7 促进胶质母细胞瘤进展。
Theranostics. 2018 Feb 7;8(6):1527-1539. doi: 10.7150/thno.22699. eCollection 2018.
8
The Ig superfamily protein PTGFRN coordinates survival signaling in glioblastoma multiforme.Ig 超家族蛋白 PTGFRN 协调胶质母细胞瘤中的存活信号。
Cancer Lett. 2019 Oct 10;462:33-42. doi: 10.1016/j.canlet.2019.07.018. Epub 2019 Aug 1.
9
EMP1 regulates cell proliferation, migration, and stemness in gliomas through PI3K-AKT signaling and CD44.上皮膜蛋白1(EMP1)通过PI3K-AKT信号通路和CD44调节胶质瘤细胞的增殖、迁移和干性。
J Cell Biochem. 2019 Oct;120(10):17142-17150. doi: 10.1002/jcb.28974. Epub 2019 May 20.
10
Exosomal circZNF800 Derived from Glioma Stem-like Cells Regulates Glioblastoma Tumorigenicity via the PIEZO1/Akt Axis.外泌体环状 ZNF800 来源于神经胶质瘤干细胞,通过 PIEZO1/Akt 轴调节神经胶质瘤的致瘤性。
Mol Neurobiol. 2024 Sep;61(9):6556-6571. doi: 10.1007/s12035-024-04002-0. Epub 2024 Feb 7.

引用本文的文献

1
Linagliptin synergizes with cPLA2 inhibition to enhance temozolomide efficacy by interrupting DPP4-mediated EGFR stabilization in glioma.利那格列汀与抑制胞浆型磷脂酶A2协同作用,通过中断二肽基肽酶4介导的表皮生长因子受体在胶质瘤中的稳定来增强替莫唑胺的疗效。
Acta Pharm Sin B. 2025 Jul;15(7):3632-3645. doi: 10.1016/j.apsb.2025.05.012. Epub 2025 May 21.
2
A tumor microenvironment model for glioma diagnosis and therapeutic evaluation based on the analysis of tissues and biological fluids.基于组织和生物流体分析的用于胶质瘤诊断和治疗评估的肿瘤微环境模型
iScience. 2025 Jun 13;28(7):112881. doi: 10.1016/j.isci.2025.112881. eCollection 2025 Jul 18.
3

本文引用的文献

1
Actionable molecular biomarkers in primary brain tumors.原发性脑肿瘤中的可操作分子生物标志物。
Trends Cancer. 2016 Jul;2(7):338-349. doi: 10.1016/j.trecan.2016.06.003.
2
Prognostic value of O-6-methylguanine-DNA methyltransferase (MGMT) protein expression in glioblastoma excluding nontumour cells from the analysis.排除非肿瘤细胞分析后 O-6-甲基鸟嘌呤-DNA 甲基转移酶(MGMT)蛋白表达在胶质母细胞瘤中的预后价值。
Neuropathol Appl Neurobiol. 2018 Feb;44(2):172-184. doi: 10.1111/nan.12415. Epub 2017 Jun 28.
3
Menin regulates Inhbb expression through an Akt/Ezh2-mediated H3K27 histone modification.
Precision exosome engineering for neurological therapeutics: molecular mechanisms and targeted strategies.
用于神经治疗的精准外泌体工程:分子机制与靶向策略
Mol Biol Rep. 2025 May 30;52(1):518. doi: 10.1007/s11033-025-10639-4.
4
Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis.当前对胶质母细胞瘤生物学、临床治疗及诊断中细胞外囊泡及其相关生物分子的理解
J Neuroimmune Pharmacol. 2025 Apr 29;20(1):48. doi: 10.1007/s11481-025-10204-7.
5
Unlocking the therapeutic potential of tumor-derived EVs in ischemia-reperfusion: a breakthrough perspective from glioma and stroke.释放肿瘤衍生细胞外囊泡在缺血再灌注中的治疗潜力:来自胶质瘤和中风的突破性观点
J Neuroinflammation. 2025 Mar 15;22(1):84. doi: 10.1186/s12974-025-03405-7.
6
Using parenclitic networks on phaeochromocytoma and paraganglioma tumours provides novel insights on global DNA methylation.对嗜铬细胞瘤和副神经节瘤肿瘤使用旁系亲属网络可提供关于全基因组DNA甲基化的新见解。
Sci Rep. 2024 Dec 2;14(1):29958. doi: 10.1038/s41598-024-81486-9.
7
Caveolae with GLP-1 and NMDA Receptors as Crossfire Points for the Innovative Treatment of Cognitive Dysfunction Associated with Neurodegenerative Diseases.GLP-1 和 NMDA 受体共存于 caveolae 作为治疗神经退行性疾病相关认知功能障碍的创新靶点。
Molecules. 2024 Aug 20;29(16):3922. doi: 10.3390/molecules29163922.
8
Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation.基于网络药理学和实验验证,五味子醇甲通过EGFR/AKT/GSK3β信号通路减轻糖尿病肾病
Biology (Basel). 2024 Aug 8;13(8):597. doi: 10.3390/biology13080597.
9
The role and application of small extracellular vesicles in glioma.小细胞外囊泡在胶质瘤中的作用及应用
Cancer Cell Int. 2024 Jun 29;24(1):229. doi: 10.1186/s12935-024-03389-z.
10
The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.胶质母细胞瘤的脂质组学特征:癌症研究中一个充满希望的前沿领域。
Cancers (Basel). 2024 Mar 8;16(6):1089. doi: 10.3390/cancers16061089.
Menin 通过 Akt/Ezh2 介导的 H3K27 组蛋白修饰调节 Inhbb 的表达。
Biochim Biophys Acta Gene Regul Mech. 2017 Apr;1860(4):427-437. doi: 10.1016/j.bbagrm.2017.02.003. Epub 2017 Feb 12.
4
Exosomes: Therapy delivery tools and biomarkers of diseases.外泌体:疾病的治疗递送工具和生物标志物。
Pharmacol Ther. 2017 Jun;174:63-78. doi: 10.1016/j.pharmthera.2017.02.020. Epub 2017 Feb 12.
5
The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells.靶向表皮生长因子受体(EGFR)第17外显子的CRISPR/Cas9系统通过对野生型/III型EGFR胶质瘤细胞中泛素化蛋白X结构域蛋白1(UBXN1)的表观遗传调控来消除核因子κB(NF-κB)的激活。
Cancer Lett. 2017 Mar 1;388:269-280. doi: 10.1016/j.canlet.2016.12.011. Epub 2016 Dec 18.
6
Immunohistochemical Analysis of ATRX, IDH1 and p53 in Glioblastoma and Their Correlations with Patient Survival.胶质母细胞瘤中ATRX、IDH1和p53的免疫组织化学分析及其与患者生存率的相关性
J Korean Med Sci. 2016 Aug;31(8):1208-14. doi: 10.3346/jkms.2016.31.8.1208. Epub 2016 May 30.
7
PTRF suppresses the progression of colorectal cancers.PTEN诱导磷酸酶(PTRF)抑制结直肠癌的进展。
Oncotarget. 2017 Jul 25;8(30):48650-48659. doi: 10.18632/oncotarget.9424.
8
AURKA induces EMT by regulating histone modification through Wnt/β-catenin and PI3K/Akt signaling pathway in gastric cancer.极光激酶A(AURKA)通过Wnt/β-连环蛋白和PI3K/Akt信号通路调节组蛋白修饰,从而在胃癌中诱导上皮-间质转化(EMT)。
Oncotarget. 2016 May 31;7(22):33152-64. doi: 10.18632/oncotarget.8888.
9
Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas.对异柠檬酸脱氢酶1/2(IDH 1/2)、α地中海贫血/智力低下综合征X连锁基因(ATRX)、p53和Ki-67进行免疫组化检测,可替代分子遗传学检测并预测Ⅲ级成人弥漫性胶质瘤患者的预后。
Brain Tumor Pathol. 2016 Apr;33(2):107-16. doi: 10.1007/s10014-016-0260-x. Epub 2016 Mar 11.
10
Blood Exosomes Endowed with Magnetic and Targeting Properties for Cancer Therapy.载磁靶向特性的血液外泌体用于癌症治疗。
ACS Nano. 2016 Mar 22;10(3):3323-33. doi: 10.1021/acsnano.5b06939. Epub 2016 Mar 7.